# Robert M. Prins

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-m-prins/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,823 |
| Field | Immunotherapy and Immune Responses |
| h-index | 52 |
| i10-index | 102 |
| Last Known Institution | APLA Health |
| OpenAlex ID | https://openalex.org/A5010449744 |
| ORCID iD | https://orcid.org/0000-0002-6282-6583 |
| Works | 481 |

## Researcher papers

- [Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma](https://scholariq.org/papers/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with/)
- [Immunotherapy response assessment in neuro-oncology: a report of the RANO working group](https://scholariq.org/papers/immunotherapy-response-assessment-in-neuro-oncology-a-report-of-the-rano-working/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)

## Researcher university

- [APLA Health](https://scholariq.org/institutions/apla-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.